InflaRx N.V. (IFRX) Corporate Subsidiaries
InflaRx N.V. (IFRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IFRX
CIK: 1708688
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG AG Wirtschaftspruefungsgesellschaft
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerStefan Schneider
Audit LocationJena, Germany
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-17 | — | SCHEDULE 13G Filing | 0001831942-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005524 | View SEC Doc Filr Page |
| 424B5 | 2026-08-14 | — | 425B5 | 0001140361-26-033149 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005206 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000908834-26-000421 | View SEC Doc Filr Page |
| EFFECT | 2026-08-12 | — | EFFECT Filing | 9999999995-26-002649 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002026 | View SEC Doc Filr Page |
| F-3 | 2026-08-06 | — | F-3 | 0001140361-26-031554 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001140361-26-031553 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | 6-K | 0001140361-26-031540 | View SEC Doc Filr Page |
| 6-K | 2026-06-30 | 2026-06-30 | 6-K | 0001140361-26-026933 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0000908834-26-000234 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-12 | — | SCHEDULE 13G Filing | 0001193125-26-219985 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | 6-K | 0001140361-26-019534 | View SEC Doc Filr Page |
| 424B5 | 2026-05-07 | — | 424B5 | 0001140361-26-019440 | View SEC Doc Filr Page |
| 424B5 | 2026-05-06 | — | 424B5 | 0001140361-26-019288 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | 6-K | 0001140361-26-019215 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-03-31 | 6-K | 0001140361-26-019211 | View SEC Doc Filr Page |
| 6-K | 2026-05-04 | 2026-05-04 | 6-K | 0001140361-26-018878 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | 6-K | 0001140361-26-017448 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-23 | 6-K | 0001140361-26-016378 | View SEC Doc Filr Page |
| 6-K | 2026-04-09 | 2026-04-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-042018 | View SEC Doc Filr Page |
| 6-K | 2026-04-02 | 2026-04-02 | 6-K | 0001140361-26-012992 | View SEC Doc Filr Page |
| 20-F | 2026-03-20 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-032065 | View SEC Doc Filr Page |
| 6-K | 2026-03-19 | 2026-03-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-031549 | View SEC Doc Filr Page |